Half a decade after Abcam quit its 270 million pound sterling pursuit of Horizon Discovery, the British antibody research expert has potentially found itself on the opposite end of the dealmaking ...
As British research supplies and tools provider Abcam moves toward a potential multibillion-dollar sale, one of the company's founders and major shareholders is pushing back. Dr. Jonathan Milner, an ...
Back in June, Abcam’s CEO Alan Hirzel and his predecessor, founder Jonathan Milner, PhD, resolved a bitter battle over the company’s direction by agreeing to explore strategic alternatives. One of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback